| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | UGT2A2 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 1.10e-15 | 35 | 36 | 8 | GO:0015020 |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | UGT2A2 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 2.49e-10 | 153 | 36 | 8 | GO:0008194 |
| GeneOntologyMolecularFunction | hexosyltransferase activity | UGT2A2 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 3.19e-09 | 211 | 36 | 8 | GO:0016758 |
| GeneOntologyMolecularFunction | glycosyltransferase activity | UGT2A2 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 3.62e-08 | 288 | 36 | 8 | GO:0016757 |
| GeneOntologyMolecularFunction | retinoic acid binding | 1.77e-07 | 28 | 36 | 4 | GO:0001972 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 1.33e-06 | 107 | 36 | 5 | GO:0033293 | |
| GeneOntologyMolecularFunction | retinoid binding | 1.64e-06 | 48 | 36 | 4 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 1.78e-06 | 49 | 36 | 4 | GO:0019840 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 6.56e-05 | 239 | 36 | 5 | GO:0031406 | |
| GeneOntologyMolecularFunction | organic acid binding | 8.74e-05 | 254 | 36 | 5 | GO:0043177 | |
| GeneOntologyMolecularFunction | C-acyltransferase activity | 6.49e-04 | 21 | 36 | 2 | GO:0016408 | |
| GeneOntologyMolecularFunction | lipid binding | 1.68e-03 | 988 | 36 | 7 | GO:0008289 | |
| GeneOntologyMolecularFunction | transporter activity | 1.76e-03 | 1289 | 36 | 8 | GO:0005215 | |
| GeneOntologyMolecularFunction | ubiquitin conjugating enzyme binding | 1.92e-03 | 36 | 36 | 2 | GO:0031624 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-sulfur bonds | 2.48e-03 | 41 | 36 | 2 | GO:0016877 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein conjugating enzyme binding | 2.60e-03 | 42 | 36 | 2 | GO:0044390 | |
| GeneOntologyMolecularFunction | G-protein alpha-subunit binding | 2.72e-03 | 43 | 36 | 2 | GO:0001965 | |
| GeneOntologyBiologicalProcess | biphenyl catabolic process | 2.12e-19 | 8 | 36 | 7 | GO:0070980 | |
| GeneOntologyBiologicalProcess | biphenyl metabolic process | 3.17e-18 | 10 | 36 | 7 | GO:0018879 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | UGT2A2 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 7.47e-18 | 21 | 36 | 8 | GO:0052695 |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 2.09e-17 | 12 | 36 | 7 | GO:0052697 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | UGT2A2 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 5.70e-17 | 26 | 36 | 8 | GO:0019585 |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | UGT2A2 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 5.70e-17 | 26 | 36 | 8 | GO:0006063 |
| GeneOntologyBiologicalProcess | hormone metabolic process | SLC5A5 UGT2B4 UGT2B7 UGT2B10 UGT2B15 SCP2 UGT2B17 IGF1R UGT2B28 DUOXA1 CEL UGT2B11 | 3.73e-14 | 286 | 36 | 12 | GO:0042445 |
| GeneOntologyBiologicalProcess | benzene-containing compound metabolic process | 2.63e-13 | 37 | 36 | 7 | GO:0042537 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 2.63e-13 | 37 | 36 | 7 | GO:0042178 | |
| GeneOntologyBiologicalProcess | androgen metabolic process | 3.22e-13 | 38 | 36 | 7 | GO:0008209 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 3.36e-12 | 52 | 36 | 7 | GO:0008210 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | UGT2A2 UGT2B4 UGT2B7 UGT2B10 UGT2B15 SCP2 UGT2B17 IGF1R UGT2B28 UGT2B11 SLC27A5 | 2.55e-11 | 376 | 36 | 11 | GO:0008202 |
| GeneOntologyBiologicalProcess | regulation of hormone levels | SLC5A5 UGT2B4 UGT2B7 UGT2B10 UGT2B15 SCP2 UGT2B17 IGF1R UGT2B28 DUOXA1 CEL UGT2B11 | 9.69e-10 | 684 | 36 | 12 | GO:0010817 |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | UGT2A2 UGT2B4 UGT2B7 UGT2B10 SCO1 UGT2B15 SCP2 UGT2B17 SLC25A42 UGT2B28 UGT2B11 SLC27A5 | 2.06e-09 | 731 | 36 | 12 | GO:0032787 |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 4.25e-09 | 141 | 36 | 7 | GO:0006805 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 9.75e-08 | 222 | 36 | 7 | GO:0071466 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | UGT2A2 UGT2B4 UGT2B7 UGT2B10 SCO1 UGT2B15 SCP2 UGT2B17 SLC25A42 UGT2B28 UGT2B11 SLC27A5 | 9.77e-08 | 1035 | 36 | 12 | GO:0019752 |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | UGT2A2 UGT2B4 UGT2B7 UGT2B10 SCO1 UGT2B15 SCP2 UGT2B17 SLC25A42 UGT2B28 UGT2B11 SLC27A5 | 1.24e-07 | 1058 | 36 | 12 | GO:0043436 |
| GeneOntologyBiologicalProcess | organic acid metabolic process | UGT2A2 UGT2B4 UGT2B7 UGT2B10 SCO1 UGT2B15 SCP2 UGT2B17 SLC25A42 UGT2B28 UGT2B11 SLC27A5 | 1.32e-07 | 1064 | 36 | 12 | GO:0006082 |
| GeneOntologyBiologicalProcess | cellular catabolic process | USP36 UGT2B4 UGT2B7 UGT2B10 UGT2B15 SCP2 UGT2B17 UGT2B28 RETREG2 CEL UGT2B11 SPTLC2 | 7.67e-07 | 1253 | 36 | 12 | GO:0044248 |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | 2.93e-05 | 525 | 36 | 7 | GO:0009410 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | 1.03e-04 | 641 | 36 | 7 | GO:1901615 | |
| GeneOntologyBiologicalProcess | bile acid metabolic process | 1.20e-04 | 55 | 36 | 3 | GO:0008206 | |
| GeneOntologyBiologicalProcess | cellular component maintenance | 7.24e-04 | 101 | 36 | 3 | GO:0043954 | |
| GeneOntologyBiologicalProcess | thyroid hormone generation | 8.66e-04 | 25 | 36 | 2 | GO:0006590 | |
| GeneOntologyCellularComponent | nuclear outer membrane | 3.49e-13 | 40 | 35 | 7 | GO:0005640 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | UGT2A2 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 DUOXA1 RETREG2 UGT2B11 SPTLC2 SLC27A5 RNF19B | 7.49e-08 | 1293 | 35 | 13 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | UGT2A2 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 DUOXA1 RETREG2 UGT2B11 SPTLC2 SLC27A5 RNF19B | 7.91e-08 | 1299 | 35 | 13 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | UGT2A2 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 DUOXA1 RETREG2 UGT2B11 SPTLC2 SLC27A5 RNF19B | 1.01e-07 | 1327 | 35 | 13 | GO:0042175 |
| GeneOntologyCellularComponent | organelle outer membrane | 3.42e-07 | 279 | 35 | 7 | GO:0031968 | |
| GeneOntologyCellularComponent | outer membrane | 3.59e-07 | 281 | 35 | 7 | GO:0019867 | |
| GeneOntologyCellularComponent | nuclear membrane | 1.53e-06 | 349 | 35 | 7 | GO:0031965 | |
| GeneOntologyCellularComponent | nuclear envelope | 3.34e-05 | 560 | 35 | 7 | GO:0005635 | |
| GeneOntologyCellularComponent | organelle envelope | UGT2B4 UGT2B7 UGT2B10 SCO1 UGT2B15 UGT2B17 SLC25A42 UGT2B28 UGT2B11 | 4.56e-04 | 1435 | 35 | 9 | GO:0031967 |
| Domain | UDPGT | 3.91e-15 | 21 | 34 | 7 | PS00375 | |
| Domain | UDPGT | 3.91e-15 | 21 | 34 | 7 | PF00201 | |
| Domain | UDP_glucos_trans | 3.91e-15 | 21 | 34 | 7 | IPR002213 | |
| Domain | E3_UB_ligase_RBR | 1.43e-04 | 10 | 34 | 2 | IPR031127 | |
| Domain | IBR | 2.89e-04 | 14 | 34 | 2 | PF01485 | |
| Domain | IBR | 2.89e-04 | 14 | 34 | 2 | SM00647 | |
| Domain | IBR_dom | 3.33e-04 | 15 | 34 | 2 | IPR002867 | |
| Domain | GPS | 1.74e-03 | 34 | 34 | 2 | SM00303 | |
| Domain | GPS | 1.84e-03 | 35 | 34 | 2 | PF01825 | |
| Domain | GPS | 1.95e-03 | 36 | 34 | 2 | PS50221 | |
| Domain | GPS | 2.06e-03 | 37 | 34 | 2 | IPR000203 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 2.40e-03 | 40 | 34 | 2 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 2.40e-03 | 40 | 34 | 2 | PS50227 | |
| Domain | GPCR_2_extracellular_dom | 2.40e-03 | 40 | 34 | 2 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 3.73e-03 | 50 | 34 | 2 | PS00650 | |
| Domain | 7tm_2 | 3.73e-03 | 50 | 34 | 2 | PF00002 | |
| Domain | GPCR_2-like | 5.33e-03 | 60 | 34 | 2 | IPR017981 | |
| Domain | GPCR_2_secretin-like | 5.33e-03 | 60 | 34 | 2 | IPR000832 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 5.50e-03 | 61 | 34 | 2 | PS50261 | |
| Pathway | REACTOME_GLUCURONIDATION | UGT2A2 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 1.09e-16 | 24 | 30 | 8 | MM14599 |
| Pathway | WP_GLUCURONIDATION | UGT2A2 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 1.60e-16 | 25 | 30 | 8 | MM15820 |
| Pathway | REACTOME_GLUCURONIDATION | UGT2A2 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 1.60e-16 | 25 | 30 | 8 | M17787 |
| Pathway | WP_GLUCURONIDATION | UGT2A2 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 2.31e-16 | 26 | 30 | 8 | M39404 |
| Pathway | REACTOME_PREDNISONE_ADME | 2.23e-14 | 23 | 30 | 7 | MM16639 | |
| Pathway | REACTOME_ASPIRIN_ADME | UGT2A2 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 2.56e-14 | 44 | 30 | 8 | M45014 |
| Pathway | REACTOME_ASPIRIN_ADME | UGT2A2 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 3.10e-14 | 45 | 30 | 8 | MM15694 |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 4.35e-14 | 25 | 30 | 7 | M605 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 1.07e-13 | 28 | 30 | 7 | M19580 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.36e-12 | 39 | 30 | 7 | MM15695 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 1.99e-12 | 41 | 30 | 7 | M7399 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 1.01e-11 | 51 | 30 | 7 | M17726 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 1.17e-11 | 52 | 30 | 7 | M14171 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 1.76e-11 | 55 | 30 | 7 | M14933 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | UGT2A2 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 4.31e-11 | 107 | 30 | 8 | MM14595 |
| Pathway | REACTOME_DRUG_ADME | UGT2A2 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 5.00e-11 | 109 | 30 | 8 | M45012 |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | UGT2A2 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 5.00e-11 | 109 | 30 | 8 | M18788 |
| Pathway | KEGG_RETINOL_METABOLISM | 5.32e-11 | 64 | 30 | 7 | M9488 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 1.02e-10 | 70 | 30 | 7 | M16794 | |
| Pathway | REACTOME_DRUG_ADME | UGT2A2 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 1.02e-10 | 119 | 30 | 8 | MM15692 |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 1.25e-10 | 72 | 30 | 7 | M9257 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | UGT2A2 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 1.30e-08 | 219 | 30 | 8 | MM14838 |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | UGT2A2 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 1.35e-08 | 220 | 30 | 8 | M10320 |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 8.76e-08 | 183 | 30 | 7 | M39588 | |
| Pathway | REACTOME_PREDNISONE_ADME | 1.95e-04 | 10 | 30 | 2 | M46430 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BILE_ACID_BIOSYNTHESIS | 3.92e-04 | 14 | 30 | 2 | M47631 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 3.92e-04 | 14 | 30 | 2 | M39328 | |
| Pathway | WP_NUCLEAR_RECEPTORS_METAPATHWAY | 4.79e-04 | 314 | 30 | 5 | M39428 | |
| Pathway | KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS | 5.16e-04 | 16 | 30 | 2 | M3214 | |
| Pathway | WP_FARNESOID_X_RECEPTOR_PATHWAY | 7.32e-04 | 19 | 30 | 2 | M39411 | |
| Pathway | WP_TAMOXIFEN_METABOLISM | 8.97e-04 | 21 | 30 | 2 | M39631 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 1.08e-03 | 23 | 30 | 2 | M1926 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 1.08e-03 | 23 | 30 | 2 | MM14741 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP5276 | 1.17e-03 | 24 | 30 | 2 | M46445 | |
| Pathway | WP_7OXOC_AND_7BETAHC_PATHWAYS | 1.49e-03 | 27 | 30 | 2 | M40054 | |
| Pathway | WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT | 1.72e-03 | 29 | 30 | 2 | M45551 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 2.22e-03 | 33 | 30 | 2 | M5967 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 2.22e-03 | 33 | 30 | 2 | MM14737 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 3.92e-03 | 44 | 30 | 2 | M499 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 4.09e-03 | 45 | 30 | 2 | MM14751 | |
| Pathway | WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL | 5.23e-03 | 51 | 30 | 2 | M39754 | |
| Pubmed | 6.84e-22 | 7 | 36 | 7 | 26074487 | ||
| Pubmed | 5.47e-21 | 8 | 36 | 7 | 32093886 | ||
| Pubmed | 6.75e-11 | 8 | 36 | 4 | 10748067 | ||
| Pubmed | 6.75e-11 | 8 | 36 | 4 | 18719240 | ||
| Pubmed | 6.75e-11 | 8 | 36 | 4 | 20142249 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 4.76e-10 | 12 | 36 | 4 | 20308471 | |
| Pubmed | 1.02e-09 | 3 | 36 | 3 | 19572376 | ||
| Pubmed | 1.02e-09 | 3 | 36 | 3 | 7835904 | ||
| Pubmed | 1.02e-09 | 3 | 36 | 3 | 23223495 | ||
| Pubmed | 1.02e-09 | 3 | 36 | 3 | 8333863 | ||
| Pubmed | 1.02e-09 | 3 | 36 | 3 | 29138287 | ||
| Pubmed | 1.02e-09 | 3 | 36 | 3 | 28882566 | ||
| Pubmed | 4.07e-09 | 4 | 36 | 3 | 26176234 | ||
| Pubmed | 4.07e-09 | 4 | 36 | 3 | 10024527 | ||
| Pubmed | 7.60e-09 | 66 | 36 | 5 | 19898482 | ||
| Pubmed | 1.02e-08 | 5 | 36 | 3 | 15318931 | ||
| Pubmed | 3.55e-08 | 7 | 36 | 3 | 20056642 | ||
| Pubmed | 5.68e-08 | 8 | 36 | 3 | 22579593 | ||
| Pubmed | 2.23e-07 | 12 | 36 | 3 | 18161889 | ||
| Pubmed | 8.22e-07 | 18 | 36 | 3 | 20056724 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 17263731 | ||
| Pubmed | Extensive metabolic consequences of human glycosyltransferase gene knockouts in prostate cancer. | 1.04e-06 | 2 | 36 | 2 | 36347965 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 24267955 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 22170718 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 10222050 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 21679149 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 32660355 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 20876810 | ||
| Pubmed | Glucuronidation of trans-3'-hydroxycotinine by UGT2B17 and UGT2B10. | 1.04e-06 | 2 | 36 | 2 | 22228205 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 15319348 | ||
| Pubmed | Localization of UDP glucuronosyltransferase gene(s) on mouse chromosome 5. | 1.04e-06 | 2 | 36 | 2 | 3105095 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 17848572 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 28962835 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 27496708 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 1909870 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 28228532 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 17687269 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 24121496 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 15666817 | ||
| Pubmed | Mouse UDP glucuronosyltransferase. cDNA and complete amino acid sequence and regulation. | 1.04e-06 | 2 | 36 | 2 | 3117546 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 17698910 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 26407805 | ||
| Pubmed | Regulation of Human UGT2B15 and UGT2B17 by miR-376c in Prostate Cancer Cell Lines. | 3.12e-06 | 3 | 36 | 2 | 26163549 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 17988216 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 18496127 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 20736324 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 26385605 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 27098059 | ||
| Pubmed | Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes. | 3.12e-06 | 3 | 36 | 2 | 18302198 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 22092298 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 30689982 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 32176075 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 16849011 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 18281521 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 26238215 | ||
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 21365123 | ||
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 16513443 | ||
| Pubmed | Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism. | 2.91e-05 | 8 | 36 | 2 | 12695355 | |
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 18052087 | ||
| Pubmed | Identification of transcripts with enriched expression in the developing and adult pancreas. | 4.01e-05 | 624 | 36 | 6 | 18554416 | |
| Pubmed | 4.71e-05 | 193 | 36 | 4 | 19343046 | ||
| Pubmed | 1.11e-04 | 750 | 36 | 6 | 11230166 | ||
| Pubmed | 2.38e-04 | 116 | 36 | 3 | 30652415 | ||
| Pubmed | The human and mouse repertoire of the adhesion family of G-protein-coupled receptors. | 4.16e-04 | 29 | 36 | 2 | 15203201 | |
| Pubmed | International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. | 5.39e-04 | 33 | 36 | 2 | 25713288 | |
| Pubmed | 7.15e-04 | 38 | 36 | 2 | 20214802 | ||
| Pubmed | 7.15e-04 | 38 | 36 | 2 | 19574343 | ||
| Pubmed | 7.40e-04 | 171 | 36 | 3 | 36629882 | ||
| Pubmed | Proteomic analysis of the mouse liver mitochondrial inner membrane. | 7.91e-04 | 175 | 36 | 3 | 12865426 | |
| Pubmed | 9.59e-04 | 44 | 36 | 2 | 20200978 | ||
| Interaction | UGT2B28 interactions | 9.56e-08 | 6 | 35 | 3 | int:UGT2B28 | |
| Interaction | UGT2B10 interactions | 2.92e-05 | 5 | 35 | 2 | int:UGT2B10 | |
| Interaction | UGT2A3 interactions | 4.38e-05 | 6 | 35 | 2 | int:UGT2A3 | |
| Interaction | UGT2B11 interactions | 6.12e-05 | 7 | 35 | 2 | int:UGT2B11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q13 | UGT2A2 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 ADGRL3 | 4.41e-15 | 157 | 36 | 9 | chr4q13 |
| Cytoband | 4q13 | 4.32e-10 | 15 | 36 | 4 | 4q13 | |
| Cytoband | 4q13.2 | 1.96e-06 | 31 | 36 | 3 | 4q13.2 | |
| Cytoband | 19p13.11 | 1.52e-03 | 73 | 36 | 2 | 19p13.11 | |
| GeneFamily | UDP glucuronosyltransferases | UGT2A2 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 1.13e-16 | 32 | 28 | 8 | 363 |
| GeneFamily | Solute carriers | 3.03e-03 | 395 | 28 | 4 | 752 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_DN | 4.43e-12 | 121 | 36 | 8 | MM935 | |
| Coexpression | VANLOO_SP3_TARGETS_DN | 8.94e-11 | 103 | 36 | 7 | MM919 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 SLC27A5 | 2.62e-10 | 201 | 36 | 8 | MM1294 |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4 | UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 SLC27A5 RNF19B | 4.98e-10 | 330 | 36 | 9 | MM1120 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP | 2.47e-09 | 267 | 36 | 8 | MM984 | |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_DN | 6.58e-09 | 190 | 36 | 7 | MM1311 | |
| Coexpression | WENG_POR_TARGETS_LIVER_UP | 1.00e-08 | 53 | 36 | 5 | MM1203 | |
| Coexpression | CUI_TCF21_TARGETS_2_UP | 1.53e-07 | 455 | 36 | 8 | MM1189 | |
| Coexpression | BOCHKIS_FOXA2_TARGETS | UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 SLC25A42 UGT2B28 UGT2B11 | 1.87e-07 | 467 | 36 | 8 | MM1233 |
| Coexpression | HOFFMAN_CLOCK_TARGETS_UP | 2.84e-07 | 10 | 36 | 3 | M2063 | |
| Coexpression | DESCARTES_ORGANOGENESIS_HEPATOCYTES | 5.23e-07 | 535 | 36 | 8 | MM3635 | |
| Coexpression | AIZARANI_LIVER_C11_HEPATOCYTES_1 | 3.00e-06 | 298 | 36 | 6 | M39115 | |
| Coexpression | GSE2585_THYMIC_DC_VS_THYMIC_MACROPHAGE_UP | 6.77e-06 | 195 | 36 | 5 | M6284 | |
| Coexpression | AMIT_SERUM_RESPONSE_60_MCF10A | 6.97e-05 | 58 | 36 | 3 | M3447 | |
| Coexpression | PILON_KLF1_TARGETS_UP | 8.65e-05 | 541 | 36 | 6 | MM1061 | |
| Coexpression | ANDERSEN_LIVER_CANCER_KRT19_DN | 1.50e-04 | 75 | 36 | 3 | M424 | |
| Coexpression | GSE19401_UNSTIM_VS_PAM2CSK4_STIM_FOLLICULAR_DC_UP | 1.51e-04 | 197 | 36 | 4 | M7670 | |
| Coexpression | GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN | 1.54e-04 | 198 | 36 | 4 | M3401 | |
| Coexpression | GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN | 1.57e-04 | 199 | 36 | 4 | M8984 | |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP | 1.57e-04 | 199 | 36 | 4 | M7414 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDC_DN | 1.60e-04 | 200 | 36 | 4 | M3826 | |
| Coexpression | VECCHI_GASTRIC_CANCER_EARLY_DN | 1.66e-04 | 382 | 36 | 5 | M15472 | |
| Coexpression | YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN | 2.46e-04 | 17 | 36 | 2 | M9914 | |
| Coexpression | AIZARANI_LIVER_C14_HEPATOCYTES_2 | 2.55e-04 | 226 | 36 | 4 | M39118 | |
| Coexpression | SMID_BREAST_CANCER_BASAL_DN | 3.47e-04 | 699 | 36 | 6 | M4960 | |
| Coexpression | HALLMARK_PEROXISOME | 3.94e-04 | 104 | 36 | 3 | M5949 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_DN | 4.64e-04 | 110 | 36 | 3 | M2396 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_DN | 4.80e-04 | 267 | 36 | 4 | M13449 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_C|TCGA-Thymus / Sample_Type by Project: Shred V9 | 2.02e-07 | 163 | 36 | 5 | 2dac87d15051151ccf193760ddd8b82534c3f922 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_C-8|TCGA-Thymus / Sample_Type by Project: Shred V9 | 7.32e-06 | 155 | 36 | 4 | 00eef9f93a753a1fe1ab5fd8dae026e7be556cde | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.83e-06 | 167 | 36 | 4 | 25af48c640e67848594f5902867ba325fc105da4 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.53e-05 | 187 | 36 | 4 | edb0ab0154542b1c0b3a2c216c4a60f0f06290b3 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.60e-05 | 189 | 36 | 4 | 7899af78b273d9c7f029d52f7e0cf6df4da41f5e | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.63e-05 | 190 | 36 | 4 | a34293601aefe5fb5c400c14091294b9ddaa195b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-05 | 194 | 36 | 4 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | background-Hepatocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.00e-05 | 200 | 36 | 4 | 423cca10df6ae0489a8fe7e7df87e70364dac022 | |
| ToppCell | background-Hepatocytes|background / Sample and Cell Type and Tumor Cluster (all cells) | 2.00e-05 | 200 | 36 | 4 | 787d35b5c2f2ad967ae14e99496a0299ac7e72fd | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.79e-04 | 158 | 36 | 3 | 8e48952af0831a1fc71ad422e8216b5a92a75991 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.79e-04 | 158 | 36 | 3 | e5b55c15a8c99c8d7fc94949f0d3c22e0c3fee7b | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.79e-04 | 158 | 36 | 3 | 55214d674808584e4d48f8c5e3b8c0e206cb9bb8 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.94e-04 | 161 | 36 | 3 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.34e-04 | 168 | 36 | 3 | e20e1936573fdde78426d7a4eb45c458d5c4dbb4 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.34e-04 | 168 | 36 | 3 | 16b517e3159ad6e6d25fd48f7d5f46e77b2b318d | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.34e-04 | 168 | 36 | 3 | d8f485f8459532a2cb0bef899e6569142cf75685 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.45e-04 | 170 | 36 | 3 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-04 | 173 | 36 | 3 | d78397e65e997ddb995111a810f0e2a4f67d0765 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-04 | 173 | 36 | 3 | 3c852ffe22f4a5b632463086b08c669310684e80 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.70e-04 | 174 | 36 | 3 | edf839d79ac58921f4e788f3b2cb2ae0d6af4b9e | |
| ToppCell | TCGA-Liver|World / Sample_Type by Project: Shred V9 | 3.70e-04 | 174 | 36 | 3 | 452932f08cf53e5949672a025d78cecb874aa4b0 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_plasma-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.70e-04 | 174 | 36 | 3 | bdbaf805a94b2f5a0065933dab6bf84e3cabd525 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.70e-04 | 174 | 36 | 3 | 271c51d220842402975d97c86c9acfdbdf62a32c | |
| ToppCell | COVID-19-kidney-PCT-S3-2|kidney / Disease (COVID-19 only), tissue and cell type | 3.70e-04 | 174 | 36 | 3 | 5aa2fb631505600f37d2b87b02def7be139dc262 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.70e-04 | 174 | 36 | 3 | 65539f69100db0b7d90b1b39ee15ab8281f86461 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 3.76e-04 | 175 | 36 | 3 | 0cc215109d9915af47e4d0a120ce2e46910715fa | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 3.82e-04 | 176 | 36 | 3 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.82e-04 | 176 | 36 | 3 | b6497324e3e52f514ce556a3fa0c3011c45dcc7b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-04 | 177 | 36 | 3 | 4943d040eee0f9dceaddc7498171281d170e271f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-04 | 177 | 36 | 3 | 3f2272b577c862dba8ccfb41184054bbd0ace6f5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-04 | 177 | 36 | 3 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.95e-04 | 178 | 36 | 3 | 066dbc4cc2083c549d98122ed44707127f34d582 | |
| ToppCell | T_cells-TFH-like_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 3.95e-04 | 178 | 36 | 3 | e2ae43e5ec31de6197f2cbd6089f944adbf0a163 | |
| ToppCell | TCGA-Liver-Solid_Tissue_Normal|TCGA-Liver / Sample_Type by Project: Shred V9 | 4.01e-04 | 179 | 36 | 3 | 7046f0a426e45fe1b41a25721ee1e33f6fc7f9e3 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-epithelial_progenitor_cell-CLDN10+_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.01e-04 | 179 | 36 | 3 | 7eca1e19ae6b5b1f18c721691dc3e860705628f2 | |
| ToppCell | TCGA-Liver-Solid_Tissue_Normal-Liver|TCGA-Liver / Sample_Type by Project: Shred V9 | 4.01e-04 | 179 | 36 | 3 | 0e22e840f43ca81a7543dcf33ec17a741cdf7f37 | |
| ToppCell | TCGA-Liver-Solid_Tissue_Normal-Liver-Liver_normal_tissue|TCGA-Liver / Sample_Type by Project: Shred V9 | 4.01e-04 | 179 | 36 | 3 | 17ba1eedb6ebf039d3b11d099351d0ac6363c8d1 | |
| ToppCell | TCGA-Liver-Solid_Tissue_Normal-Liver-Liver_normal_tissue-2|TCGA-Liver / Sample_Type by Project: Shred V9 | 4.01e-04 | 179 | 36 | 3 | a20bb3ace5be10c5aef330e9268c0ba55f8fee23 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-04 | 181 | 36 | 3 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-04 | 181 | 36 | 3 | 071f9bb5d39070cdc473d9b0e094d196bc702b56 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.21e-04 | 182 | 36 | 3 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | 367C-Myeloid-Dendritic-cDC1|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.21e-04 | 182 | 36 | 3 | 6f5228ac47f9ab46d165740cf2655b5ba217acbe | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.35e-04 | 184 | 36 | 3 | da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.35e-04 | 184 | 36 | 3 | fa4915b0498f3069fd5ef497286445528f75187e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-04 | 185 | 36 | 3 | 7092436b4db90289516ed130ade596e3021cffaf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-04 | 185 | 36 | 3 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-04 | 185 | 36 | 3 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-04 | 185 | 36 | 3 | a8ca7819066d5297ef6966e7f3e2c9f8a7673fdc | |
| ToppCell | P03|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.42e-04 | 185 | 36 | 3 | a07dbe1f76e40734a28826423a5cc64b8e56af5e | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.49e-04 | 186 | 36 | 3 | 8ea708070166c858cd9bd871670655b0114c32a5 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.56e-04 | 187 | 36 | 3 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.56e-04 | 187 | 36 | 3 | 530e4e6d91b5c0d9aa4543caa2b734a1674c5788 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.56e-04 | 187 | 36 | 3 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.56e-04 | 187 | 36 | 3 | ec4b694487cc446999c7b27b119950a4f252c4b3 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.70e-04 | 189 | 36 | 3 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.70e-04 | 189 | 36 | 3 | c8b8f860aaf6c73863cd79941db6b469c830ef06 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 5.00e-04 | 193 | 36 | 3 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | moderate-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.00e-04 | 193 | 36 | 3 | 22455801194bd8c73c5c397f5eac4f723429c383 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.08e-04 | 194 | 36 | 3 | c5ef4ff73b4e51530656002e3a2fb7264cdf533d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.15e-04 | 195 | 36 | 3 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.15e-04 | 195 | 36 | 3 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.23e-04 | 196 | 36 | 3 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.23e-04 | 196 | 36 | 3 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.23e-04 | 196 | 36 | 3 | 69ad90a429af4dad5a45556544224001ebcb1607 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle-Smooth_muscle_L.2.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.23e-04 | 196 | 36 | 3 | 4da96672a9c72268cfcc82d61eb3caae6e02d4c4 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.23e-04 | 196 | 36 | 3 | f78951b460913866d092ba92af70ea76a2afa73e | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell-B_naive|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.23e-04 | 196 | 36 | 3 | de43dd0697e1daf4d50800957cf0b27b54a7a333 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.23e-04 | 196 | 36 | 3 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.23e-04 | 196 | 36 | 3 | 65e161fd672e37a5d10f28011bb422c4d7042d6a | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.31e-04 | 197 | 36 | 3 | 236a40eb6c08e1d179cf0fb5450b032975c5f6b6 | |
| ToppCell | Enterocyte-C_01|Enterocyte / shred on cell type and cluster | 5.39e-04 | 198 | 36 | 3 | 4e2c30d6fd1d59db98a52bfcc3206b4c4ac5abe2 | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.39e-04 | 198 | 36 | 3 | d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-A_(AT2)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.46e-04 | 199 | 36 | 3 | 09cf004032e5af912ee0cdde6e24ce3bcf7673cd | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.46e-04 | 199 | 36 | 3 | a697b3f0760e66bad8ea8d83cf6fea5934692c56 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Neuronal-Intermediate|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 5.55e-04 | 200 | 36 | 3 | 401d50fa394fa863fa7836344110ae5c7af3250a | |
| ToppCell | 356C-Endothelial_cells-Endothelial-A_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.55e-04 | 200 | 36 | 3 | fa99901388eec28004bef85d84f0d7d5bd4df4a8 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-A_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.55e-04 | 200 | 36 | 3 | 89eae23195d57f1b23a337ff19c9b8a367e22c96 | |
| ToppCell | Influenza|World / Disease, condition lineage and cell class | 5.55e-04 | 200 | 36 | 3 | df996c35907a1c9194b9e2ca30e81f520ca067f0 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.55e-04 | 200 | 36 | 3 | eb44d1f80ecaac3a022cd04ab16dc36151e45488 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.55e-04 | 200 | 36 | 3 | ac8a5d71acd4d401995babd233f0d3738e8ad2a5 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.55e-04 | 200 | 36 | 3 | acc771a902cf2f060c3eb9aedb72a256f5778a6c | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT2-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 5.55e-04 | 200 | 36 | 3 | ceb613ac6cdf0e3e6bb3f04d89034e18a524cefb | |
| Computational | Steroid hormone and heme metabolism. | 5.63e-08 | 16 | 27 | 4 | MODULE_505 | |
| Computational | Genes in the cancer module 227. | 6.30e-06 | 15 | 27 | 3 | MODULE_227 | |
| Drug | C1 11-32 | 3.36e-16 | 18 | 35 | 7 | CID000443077 | |
| Drug | C11131 | 3.36e-16 | 18 | 35 | 7 | CID000443076 | |
| Drug | T4-G | 5.32e-16 | 19 | 35 | 7 | CID000152424 | |
| Drug | estriol-16-glucuronide | 1.23e-15 | 21 | 35 | 7 | CID000122281 | |
| Drug | estradiol-3-glucuronide | 2.58e-15 | 23 | 35 | 7 | CID000066651 | |
| Drug | L-idaro-1,4-lactone | 1.24e-14 | 28 | 35 | 7 | CID000078997 | |
| Drug | 7-hydroxycoumarin glucuronide | 1.63e-14 | 29 | 35 | 7 | CID000125641 | |
| Drug | 1-naphthol | UGT2B4 UGT2B7 UGT2B10 UGT2B15 SCP2 UGT2B17 UGT2B28 ADGRV1 UGT2B11 | 2.24e-14 | 98 | 35 | 9 | CID000007005 |
| Drug | AC1Q6OQG | 4.44e-14 | 33 | 35 | 7 | CID000009686 | |
| Drug | BP-3,6-quinol | 4.44e-14 | 33 | 35 | 7 | CID000119292 | |
| Drug | AC1NOWCJ | 6.98e-14 | 35 | 35 | 7 | CID005120112 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 6.98e-14 | 35 | 35 | 7 | CID010436171 | |
| Drug | estrone-3-glucuronide | 6.98e-14 | 35 | 35 | 7 | CID000115255 | |
| Drug | l-borneol | 1.07e-13 | 37 | 35 | 7 | CID000010049 | |
| Drug | harmol | 1.92e-13 | 40 | 35 | 7 | CID000068094 | |
| Drug | testosterone glucuronide | 2.32e-13 | 41 | 35 | 7 | CID000108192 | |
| Drug | 2-AF | 2.32e-13 | 41 | 35 | 7 | CID000005800 | |
| Drug | androsterone glucuronide | 3.32e-13 | 43 | 35 | 7 | CID000114833 | |
| Drug | 7,8-benzoquinoline | 3.32e-13 | 43 | 35 | 7 | CID000009191 | |
| Drug | MS-222 | 3.94e-13 | 44 | 35 | 7 | CID000011400 | |
| Drug | salicylamide | 7.53e-13 | 48 | 35 | 7 | CID000005147 | |
| Drug | 2-naphthol | 1.22e-12 | 93 | 35 | 8 | CID000008663 | |
| Drug | AC1NQGK1 | 1.36e-12 | 52 | 35 | 7 | CID005195977 | |
| Drug | oxazepam | 1.57e-12 | 53 | 35 | 7 | CID000004616 | |
| Drug | 7-methoxycoumarin | 2.68e-12 | 57 | 35 | 7 | CID000010748 | |
| Drug | phenolphthalein | 3.04e-12 | 58 | 35 | 7 | CID000004764 | |
| Drug | urochloralic acid | 3.45e-12 | 59 | 35 | 7 | CID003036914 | |
| Drug | 4-hydroxybiphenyl | 3.45e-12 | 59 | 35 | 7 | CID000007103 | |
| Drug | 4-hydroxyestrone | 3.45e-12 | 59 | 35 | 7 | CID000018418 | |
| Drug | acetaminophen glucuronide | 3.45e-12 | 59 | 35 | 7 | CID000083944 | |
| Drug | SN-38G | 3.45e-12 | 59 | 35 | 7 | CID000443154 | |
| Drug | phenolate | UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 DUOXA1 CEL UGT2B11 TRIB1 | 3.59e-12 | 254 | 35 | 10 | CID000000996 |
| Drug | UDP-alpha-d-xylopyranose | 3.90e-12 | 60 | 35 | 7 | CID000001165 | |
| Drug | 2-naphthylamine | UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 DUOXA1 UGT2B11 | 4.84e-12 | 110 | 35 | 8 | CID000007057 |
| Drug | 3-OHBaP | 5.57e-12 | 63 | 35 | 7 | CID000025890 | |
| Drug | lithocholic acid | UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 SLC27A5 | 7.46e-12 | 116 | 35 | 8 | CID000009903 |
| Drug | Meldola | 9.71e-12 | 68 | 35 | 7 | CID000081507 | |
| Drug | methoxyresorufin | 1.08e-11 | 69 | 35 | 7 | CID000119220 | |
| Drug | sodium cholate | UGT2B4 UGT2B7 UGT2B10 UGT2B15 SCP2 UGT2B17 TNFRSF10D UGT2B28 CEL UGT2B11 SLC27A5 | 1.52e-11 | 408 | 35 | 11 | CID000000303 |
| Drug | 2,2,2-trichloroethanol | 1.62e-11 | 73 | 35 | 7 | CID000008259 | |
| Drug | eugenol | 1.62e-11 | 73 | 35 | 7 | CID000003314 | |
| Drug | 7-hydroxycoumarin | 1.97e-11 | 75 | 35 | 7 | CID005281426 | |
| Drug | 16-epiestriol | 2.39e-11 | 77 | 35 | 7 | CID000003269 | |
| Drug | AC1N8H7N | 2.62e-11 | 78 | 35 | 7 | CID004318740 | |
| Drug | benzyloxyresorufin | 2.62e-11 | 78 | 35 | 7 | CID000114982 | |
| Drug | oltipraz | UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 ADGRV1 UGT2B11 | 2.87e-11 | 137 | 35 | 8 | CID000047318 |
| Drug | acridine | 3.43e-11 | 81 | 35 | 7 | CID000009215 | |
| Drug | 5 alpha-androstane | 4.46e-11 | 84 | 35 | 7 | CID000094144 | |
| Drug | 2 E1 | UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 SLC27A5 | 4.53e-11 | 145 | 35 | 8 | CID006102788 |
| Drug | 7-ethoxycoumarin | 5.28e-11 | 86 | 35 | 7 | CID000035703 | |
| Drug | menthol | 5.73e-11 | 87 | 35 | 7 | CID000001254 | |
| Drug | pentoxyresorufin | 5.73e-11 | 87 | 35 | 7 | CID000107683 | |
| Drug | 3 -hydroxypregn-5-en-20-one | UGT2B4 UGT2B7 UGT2B10 UGT2B15 SCP2 UGT2B17 UGT2B28 CEL UGT2B11 | 7.14e-11 | 238 | 35 | 9 | CID000001027 |
| Drug | 4-aminobiphenyl | 8.55e-11 | 92 | 35 | 7 | CID000007102 | |
| Drug | p-nitroanisole | 8.55e-11 | 92 | 35 | 7 | CID000007485 | |
| Drug | DCNB | 1.07e-10 | 95 | 35 | 7 | CID000007443 | |
| Drug | ethoxyresorufin | 1.07e-10 | 95 | 35 | 7 | CID000003294 | |
| Drug | DB04103 | 1.25e-10 | 97 | 35 | 7 | CID004469987 | |
| Drug | 3-hydroxyandrostan-17-one | 1.78e-10 | 102 | 35 | 7 | CID000000225 | |
| Drug | chrysin | 2.34e-10 | 106 | 35 | 7 | CID005281607 | |
| Drug | fluconazole | 2.50e-10 | 107 | 35 | 7 | CID000003365 | |
| Drug | Hymecromone | 3.31e-10 | 25 | 35 | 5 | ctd:D006923 | |
| Drug | ethoxyquin | 4.43e-10 | 116 | 35 | 7 | CID000003293 | |
| Drug | AC1Q7AUJ | 4.71e-10 | 117 | 35 | 7 | CID000003303 | |
| Drug | fibrates | 5.00e-10 | 118 | 35 | 7 | CID000002797 | |
| Drug | alpha-naphthoflavone | 5.00e-10 | 118 | 35 | 7 | CID000011790 | |
| Drug | dimethylnitrosamine | 5.04e-10 | 196 | 35 | 8 | CID000006124 | |
| Drug | benzphetamine | 5.31e-10 | 119 | 35 | 7 | CID000002341 | |
| Drug | UDP-N-acetylglucosamine | UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 ADGRL3 | 6.66e-10 | 203 | 35 | 8 | CID000001167 |
| Drug | hexobarbital | 8.40e-10 | 127 | 35 | 7 | CID000003608 | |
| Drug | AC1L1FK5 | 9.37e-10 | 129 | 35 | 7 | CID000003272 | |
| Drug | 4-methylumbelliferone | 1.10e-09 | 132 | 35 | 7 | CID003364573 | |
| Drug | NNAL | 1.25e-09 | 32 | 35 | 5 | CID000104856 | |
| Drug | aniline | 1.84e-09 | 142 | 35 | 7 | CID000006115 | |
| Drug | 3-methylcholanthrene | UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 TNFRSF10D UGT2B28 UGT2B11 | 1.85e-09 | 231 | 35 | 8 | CID000001674 |
| Drug | butylated hydroxytoluene | 1.93e-09 | 143 | 35 | 7 | CID000031404 | |
| Drug | 2-methoxyestradiol | UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 TNFRSF10D UGT2B28 UGT2B11 | 2.19e-09 | 236 | 35 | 8 | CID000001573 |
| Drug | UDP-glucose | 3.13e-09 | 247 | 35 | 8 | CID000001166 | |
| Drug | disulfiram | 3.87e-09 | 158 | 35 | 7 | CID000003117 | |
| Drug | AC1LCF1F | 4.42e-09 | 161 | 35 | 7 | CID000627275 | |
| Drug | 2-acetylaminofluorene | SLC5A5 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 4.97e-09 | 262 | 35 | 8 | CID000005897 |
| Drug | al-Badry | 5.24e-09 | 165 | 35 | 7 | CID000004545 | |
| Drug | estrone-d4 | 5.94e-09 | 168 | 35 | 7 | CID000000698 | |
| Drug | acetaminophen | UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 TNFRSF10D UGT2B28 UGT2B11 | 6.29e-09 | 270 | 35 | 8 | CID000001983 |
| Drug | aminopyrine | 6.71e-09 | 171 | 35 | 7 | CID000006009 | |
| Drug | glucosiduronate | 6.71e-09 | 171 | 35 | 7 | CID000000610 | |
| Drug | 4-nitrophenol | 8.53e-09 | 177 | 35 | 7 | CID000000980 | |
| Drug | pheophytin | 9.33e-09 | 284 | 35 | 8 | CID000000250 | |
| Drug | SN-38 | 1.12e-08 | 184 | 35 | 7 | CID000104842 | |
| Drug | DNCB | 1.34e-08 | 189 | 35 | 7 | CID000000006 | |
| Drug | uridine 5'-diphosphoglucuronic acid | 1.34e-08 | 189 | 35 | 7 | CID000000390 | |
| Drug | thryroxine | SLC5A5 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 1.51e-08 | 302 | 35 | 8 | CID000000853 |
| Drug | 2-butyl-6-methoxyphenol | 1.79e-08 | 197 | 35 | 7 | CID011954184 | |
| Drug | clofibrate | UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 UGT2B28 UGT2B11 SLC27A5 | 1.89e-08 | 311 | 35 | 8 | CID000002796 |
| Drug | beta-naphthoflavone | 1.98e-08 | 200 | 35 | 7 | CID000002361 | |
| Drug | N'-nitrosoanatabine | 2.23e-08 | 20 | 35 | 4 | CID000051291 | |
| Drug | AC1L1OBF | 2.23e-08 | 20 | 35 | 4 | CID000032736 | |
| Drug | Aroclor 1254 | 3.06e-08 | 213 | 35 | 7 | CID000040470 | |
| Drug | Amobarbital | 3.32e-08 | 5 | 35 | 3 | ctd:D000654 | |
| Drug | phenolphthalin | 3.32e-08 | 5 | 35 | 3 | CID000066494 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 2.19e-13 | 9 | 35 | 5 | EFO_0600040 | |
| Disease | X-19141 measurement | 2.23e-12 | 13 | 35 | 5 | EFO_0800799 | |
| Disease | X-24947 measurement | 4.52e-11 | 22 | 35 | 5 | EFO_0800910 | |
| Disease | deoxycholic acid glucuronide measurement | 1.16e-10 | 8 | 35 | 4 | EFO_0800575 | |
| Disease | vanillylmandelate (VMA) measurement | 5.33e-08 | 7 | 35 | 3 | EFO_0800119 | |
| Disease | phosphatidylcholine 36:4 measurement | 1.23e-06 | 18 | 35 | 3 | EFO_0010382 | |
| Disease | X-12007 measurement | 1.37e-06 | 2 | 35 | 2 | EFO_0021276 | |
| Disease | androsterone glucuronide measurement | 1.72e-06 | 20 | 35 | 3 | EFO_0800317 | |
| Disease | metabolite measurement | 3.62e-06 | 560 | 35 | 7 | EFO_0004725 | |
| Disease | serum clozapine-to-N-desmethylclozapine ratio measurement | 4.10e-06 | 3 | 35 | 2 | EFO_0600042 | |
| Disease | cholic acid glucuronide measurement | 4.10e-06 | 3 | 35 | 2 | EFO_0800574 | |
| Disease | X-25937 measurement | 8.19e-06 | 4 | 35 | 2 | EFO_0800937 | |
| Disease | X-16576 measurement | 8.19e-06 | 4 | 35 | 2 | EFO_0800760 | |
| Disease | vitamin D deficiency | 1.16e-05 | 37 | 35 | 3 | EFO_0003762 | |
| Disease | cotinine measurement, trans-3-hydroxycotinine measurement | 2.04e-05 | 6 | 35 | 2 | EFO_0007813, EFO_0010707 | |
| Disease | cortolone glucuronide (1) measurement | 2.04e-05 | 6 | 35 | 2 | EFO_0800552 | |
| Disease | X-24574 measurement | 2.86e-05 | 7 | 35 | 2 | EFO_0800897 | |
| Disease | X-24418 measurement | 2.86e-05 | 7 | 35 | 2 | EFO_0800879 | |
| Disease | omega-6:omega-3 polyunsaturated fatty acid ratio | 2.88e-05 | 50 | 35 | 3 | EFO_0010732 | |
| Disease | serum N-desmethylclozapine measurement | 3.81e-05 | 8 | 35 | 2 | EFO_0600043 | |
| Disease | X-12844 measurement | 4.89e-05 | 9 | 35 | 2 | EFO_0021339 | |
| Disease | disease progression measurement | 5.25e-05 | 61 | 35 | 3 | EFO_0008336 | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 6.11e-05 | 10 | 35 | 2 | EFO_0022090 | |
| Disease | HMG CoA reductase inhibitor use measurement | 7.31e-05 | 189 | 35 | 4 | EFO_0009932 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 7.47e-05 | 11 | 35 | 2 | EFO_0801531 | |
| Disease | plasma N-desmethylclozapine measurement | 7.47e-05 | 11 | 35 | 2 | EFO_0600039 | |
| Disease | serum gamma-glutamyl transferase measurement | 8.42e-05 | 914 | 35 | 7 | EFO_0004532 | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 8.95e-05 | 12 | 35 | 2 | EFO_0800291 | |
| Disease | testosterone measurement | 9.86e-05 | 1275 | 35 | 8 | EFO_0004908 | |
| Disease | X-11444 measurement | 1.06e-04 | 13 | 35 | 2 | EFO_0021237 | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 1.06e-04 | 13 | 35 | 2 | EFO_0800293 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 1.23e-04 | 14 | 35 | 2 | EFO_0800283 | |
| Disease | alkaline phosphatase measurement | 1.61e-04 | 1015 | 35 | 7 | EFO_0004533 | |
| Disease | urinary metabolite measurement | 1.98e-04 | 245 | 35 | 4 | EFO_0005116 | |
| Disease | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | 2.07e-04 | 18 | 35 | 2 | EFO_0800288 | |
| Disease | cotinine glucuronidation measurement | 2.31e-04 | 19 | 35 | 2 | EFO_0006508 | |
| Disease | etiocholanolone glucuronide measurement | 2.31e-04 | 19 | 35 | 2 | EFO_0800362 | |
| Disease | cotinine measurement | 3.40e-04 | 23 | 35 | 2 | EFO_0007813 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 3.72e-04 | 118 | 35 | 3 | EFO_0010119 | |
| Disease | epiandrosterone sulfate measurement | 4.03e-04 | 25 | 35 | 2 | EFO_0021120 | |
| Disease | docosahexaenoic acid measurement | 4.61e-04 | 127 | 35 | 3 | EFO_0007761 | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 5.07e-04 | 28 | 35 | 2 | DOID:4194 (implicated_via_orthology) | |
| Disease | osteoporosis (is_implicated_in) | 6.22e-04 | 31 | 35 | 2 | DOID:11476 (is_implicated_in) | |
| Disease | vitamin D measurement | 6.54e-04 | 336 | 35 | 4 | EFO_0004631 | |
| Disease | androsterone sulfate measurement | 7.05e-04 | 33 | 35 | 2 | EFO_0021117 | |
| Disease | uric acid measurement | 7.22e-04 | 610 | 35 | 5 | EFO_0004761 | |
| Disease | neuritic plaque measurement | 7.54e-04 | 349 | 35 | 4 | EFO_0006798 | |
| Disease | malignant epithelial tumor of ovary | 7.94e-04 | 35 | 35 | 2 | MONDO_0018364 | |
| Disease | obsolete_red blood cell distribution width | 8.88e-04 | 1347 | 35 | 7 | EFO_0005192 | |
| Disease | lean body mass | 1.02e-03 | 379 | 35 | 4 | EFO_0004995 | |
| Disease | lymphocyte percentage of leukocytes | 1.06e-03 | 665 | 35 | 5 | EFO_0007993 | |
| Disease | high density lipoprotein particle size measurement | 1.07e-03 | 170 | 35 | 3 | EFO_0008592 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MPIHVYSGIVIFGTV | 156 | Q53TN4 | |
| IGYGSFMYPVVLQVH | 366 | A4D0V7 | |
| YLVGYGMPALIVAVS | 971 | Q9HAR2 | |
| GLIMIPVVRLHGTYG | 4416 | Q8WXG9 | |
| GLEYPMLHYVGFVPV | 296 | P19835 | |
| IIDVVAIMPYYIGLV | 261 | Q9UK17 | |
| LIVGGLVIMLYVFHR | 946 | P08069 | |
| LAYYVPMIGLSIVHR | 251 | Q9H342 | |
| LKMHYLPVIYGIIFL | 31 | Q96P68 | |
| ITLLGVMYLYVGPSL | 776 | Q14008 | |
| LILPGFGMISHIVTY | 246 | P00395 | |
| ELGMYYHLLVQIPIF | 206 | Q99680 | |
| PVLVYGGYMLLATGI | 201 | Q1HG43 | |
| YIVDHTIIMYLIGPD | 256 | O75880 | |
| VGIGVPIMLAYVYGV | 421 | Q6ZMZ0 | |
| MVLVHVGYLVLPVFG | 1 | Q6ZSG1 | |
| VLAVLGHYVPGIMIS | 196 | Q8NC44 | |
| GHYVPGIMISYIVLL | 201 | Q8NC44 | |
| LYHGFMPTVLGVIPY | 186 | Q86VD7 | |
| LGVLLYILVHGTMPF | 236 | Q9H093 | |
| IYHSLGMTGIPIINV | 76 | P22307 | |
| TILGMLASPYHYLII | 201 | Q9UBN6 | |
| GVMLYTLLVGRYPFH | 271 | Q96RU8 | |
| GIGVPIMLAYVYGVV | 436 | Q9NV58 | |
| TMLYTGIVIYAPALI | 141 | Q92911 | |
| YTVLPLYHVMGLVVG | 331 | Q9Y2P5 | |
| YEAIYHGIPMVGVPL | 381 | P06133 | |
| TPMLVAVLTYVGYGV | 66 | O15270 | |
| YEAIYHGIPMVGIPL | 381 | O75310 | |
| ANGIYEAIYHGIPMV | 376 | P36537 | |
| IYEAIYHGIPMVGIP | 381 | P54855 | |
| YEAIYHGIPMVGIPL | 381 | Q9BY64 | |
| YEAIYHGIPMVGIPL | 381 | P16662 | |
| MIYGLIVGVILRYGT | 106 | Q96T83 | |
| YGLVGYMRIIIKEHP | 156 | Q13564 | |
| MQLVYTSGVYHIAGP | 331 | Q63HR2 | |
| DPVMYGLYAVLVHSG | 361 | Q9P275 | |
| IYEAIYHGIPMVGIP | 381 | O75795 | |
| GIYEAIYHGVPMVGV | 386 | P0DTE5 |